期刊文献+

阻断TLR2和TLR4缓解UVB导致的HaCaT细胞损伤作用 被引量:1

Blocking of TLR2 and TLR4 alleviates adverse effects of UVB on HaCaT cells
下载PDF
导出
摘要 目的:本文拟探讨阻断TLR2和TLR4能否缓解紫外线(UVB)导致的人角质形成细胞株-HaCaT细胞损伤作用并探讨其可能的作用机制。方法:采用MTT法确定UVB最佳照射剂量以及C_(29)和TAK-242的最佳作用浓度;Western blot检测细胞凋亡、NF-κB和内质网应激相关蛋白的表达,探讨阻断TLR2和TLR4缓解UVB导致的HaCaT细胞损伤的作用机制。结果:90 s后细胞存活率明显低于对照组,确定UVB最佳照射时间为90 s;阻断TLR2、TLR4后,UVB导致的HaCaT细胞损伤降低,且150μmol/L C_(29)和2μmol/L TAK-242效果最好;与TLR2相比,阻断TLR4后凋亡蛋白Caspase-8,氧化应激蛋白NF-κB、pNF-κB以及内质网应激蛋白p-PERK的表达下降显著,二者抑制剂联合使用效果更加显著。结论:阻断TLR2和TLR4可以抑制UVB导致的人角质形成细胞HaCaT的损伤和凋亡,其可能是通过抑制细胞NF-κB通路和内质网应激发挥作用。 Objective:The study was to explore whether the blocking of Toll like receptor-2(TLR2)and TLR4 would alleviate the adverse effects of Ultraviolet radiation B(UVB)on human keratinocyte-HaCaT cells and possible underlying mechanisms.Methods:MTT method was used to determine the most appropriate dose of UVB,appropriate concentration of C_(29) and TAK-242.Western blot was employed to detect the expression of apoptosis related protein,NF-κB and endoplasmic reticulum stress-related proteins to investigate the possible mechanisms underlying the alleviating effects of blocking TLR2 and TLR4 on the damage of HaCaT cells caused by UVB.Results:The irradiation time of UVB was determined at 90 s since the survival rate of the cells irradiated for 90 s was significantly decreased compared with that of the cells from control.Blocking TLR2 and TLR4 reduced the damage caused by UVB to HaCaT cells and 150μmo/l L C_(29) and 2μmo/l L TAK-242 are the best.Compared with blocking TLR2,blocking TLR4 significantly decreased the expression of Caspase-8,NF-κB,p-NF-κB and p-PERK even further.Moreover,the combination of C_(29) and TAK-242 could produce a better effects against UVB damage.Conclusion:Blocking TLR2 and TLR4 could inhibit the HaCaT cell apoptosis and decrease the damage caused by UVB to HaCaT cells;and the possible underlying mechanisms may be that the blocking alleviates the damage through the inhibition of NF-κB pathway and endoplasmic reticulum stress.
作者 杨慧 李浩 冯立爽 杨卓东 杨煜 YANG Hui;LI Hao;FENG Li-Shuang;YANG Zhuo-Dong;YANG Yu(Experimental Teaching Center of Preventive Medicine,School of Public Health,Jilin University,Changchun 130021,China)
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2021年第17期2070-2075,共6页 Chinese Journal of Immunology
基金 复旦大学附属中山医院放射诊疗建设项目放射性职业病评价项目(3R219F143427)资助。
关键词 UVB TLR2 TLR4 UVB TLR2 TLR4
  • 相关文献

参考文献2

二级参考文献15

  • 1Sheedy F J, Grebe A, Rayner K J, Kalantari P, Ramkhelawon B, Carpenter SB et al. CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat Imrnunol 2013; 14: 812-820.
  • 2Manning-Tobin J J, Moore K J, Seimon TA, Bell SA, Sharuk M, Alvarez-Leite JI, et al. Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice. Arterioscler Thromb Vasc Bio12009; 29: 19-26.
  • 3Stewart CR, Stuart LM, Wilkinson K, van Gils JM, Deng J, Halle A etal. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immuno12010: 11: 155-161.
  • 4Seimon TA, Nadolski M J, Liao X, Magallon J, Nguyen M, Feric NT et aL Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. Cell Metab 2010; 12: 467-482.
  • 5Duewell P, Kono H, Rayner K J, Sirois CM, Vladimer G, Bauernfeind FG et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010; 464: 1357-1361.
  • 6Rajamaki K, Lappalainen J, Oomi K, Valimaki E, Matikainen S, Kovanen PT et al. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PIoS ONE 2010; 5: e11765.
  • 7Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma Met al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006; 440: 228-232.
  • 8Lamkanfi M, Dixit VM. Inflammasomes and their roles in health and disease. Annu Rev Cell Dev Biol 2012; 28: 137-161.
  • 9Juliana C, Fernandes-Alnemri T, Kang S, Farias A, Qin F, Alnemri ES. Non-transcriptional priming and deubiquitination regulate NLRP3 infiammasome activation. J Biol Chem 2012; 287: 36617-36622.
  • 10Py BF, Kim MS, Vakifahmetoglu-Norberg H, Yuan J. Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity. Mol Cell 2013; 49: 331-338.

共引文献10

同被引文献11

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部